Clinical Trial Update: Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer

View source ↗

Summary

Clinical trial update for TheraSphere (yttrium-90 glass microspheres) in unresectable primary liver cancer and liver metastases; the trial is no longer availabl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Metastases

Drugs mentioned

• TheraSphere (yttrium-90 glass microspheres)

Snippet

Sponsor: Leo W. Jenkins Cancer Center | Conditions: Carcinoma, Hepatocellular, Neoplasm Metastasis | Status: NO_LONGER_AVAILABLE